{"result": {"id": "73867fe0-7354-40c1-a77a-0696770831c8", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>HYPERTENSION<|>EVENT<|>Hypertension is a medical condition characterized by high blood pressure, which is a significant risk factor for PAD and increases cardiovascular events in PAD patients.\")\n##\n(\"entity\"<|>CKD<|>EVENT<|>Chronic Kidney Disease (CKD) is a condition where patients with PAD and hypertension may require stricter blood pressure control (<130/80mmHg if tolerated).\")\n##\n(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a comorbidity that, when present with PAD and hypertension, requires stricter blood pressure control (<130/80mmHg if tolerated).\")\n##\n(\"entity\"<|>CARDIOVASCULAR EVENTS<|>EVENT<|>Cardiovascular events are complications that PAD patients with hypertension are at increased risk of experiencing.\")\n##\n(\"entity\"<|>BLOOD PRESSURE CONTROL<|>EVENT<|>Blood pressure control is a critical treatment goal for PAD patients with hypertension, with specific target ranges recommended.\")\n##\n(\"relationship\"<|>HYPERTENSION<|>PAD<|>Hypertension is a significant risk factor for the development and progression of PAD.<|>8)\n##\n(\"relationship\"<|>HYPERTENSION<|>CARDIOVASCULAR EVENTS<|>Hypertension increases the risk of cardiovascular events in PAD patients.<|>7)\n##\n(\"relationship\"<|>PAD<|>CARDIOVASCULAR EVENTS<|>PAD patients have increased risk of cardiovascular events, which can be reduced with proper blood pressure management.<|>7)\n##\n(\"relationship\"<|>DIABETES<|>BLOOD PRESSURE CONTROL<|>Patients with diabetes and PAD require stricter blood pressure control targets (<130/80mmHg if tolerated).<|>6)\n##\n(\"relationship\"<|>CKD<|>BLOOD PRESSURE CONTROL<|>Patients with CKD and PAD require stricter blood pressure control targets (<130/80mmHg if tolerated).<|>6)\n##\n(\"relationship\"<|>BLOOD PRESSURE CONTROL<|>CARDIOVASCULAR EVENTS<|>Proper blood pressure control reduces cardiovascular events in PAD patients.<|>7)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558750, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 505, "prompt_tokens": 3021, "total_tokens": 3526, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2944}, "prompt_cache_hit_tokens": 2944, "prompt_cache_miss_tokens": 77}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 和血管扩张药 ,包括硝普钠或乌拉地尔 。若病情较轻 ,  可以在 24~48h 内逐渐降压 ;病情重伴有急性肺水肿  的患者在初始 1 h 内平均动脉压的降低幅度不超过治  疗前 水 平 的 25% , 2~ 6 h 内 使 血 压 下 降 至 160/ 100mmHg,24~48h 内使血压逐渐降至正常。\n8.5   高血压合并外周动脉疾病(PAD)\n\n要点 8E   高血压合并外周动脉疾病(PAD)\n　　　· 合并 PAD 的高血压患者 , 血压应控制在 < 140/90mmHg;对于存在糖尿病和 CKD 的患者 ,如 能耐受 ,血压应控制在<130/80mmHg( Ⅰ ,A) 。\n　　　· ACEI或 ARB 可 作 为 初 始 降 压 治 疗 药 ( Ⅱa,B) ,CCB及利尿剂可作为此类患者初始联合降 压治疗方案( Ⅱa,B) ,β受体阻滞剂也可以考虑应用 ( Ⅱb,C) 。\n　　　·合并症状性颅外颈动脉狭窄的患者 ,除非患者 处 于 脑 卒 中 超 急 性 期 , 降 压 治 疗 可 能 是 合 理 的 ( Ⅱa,C) 。\n\n　8.5.1  流行病学特点和降压治疗获益   PAD在普通  人群中的患病率为 3%~ 10% ,在 70岁以上老年人中  高达 15%~ 20%[578] 。高血压是 PAD发生和发展的  重要危险因素 , 多达 55%的 PAD 患者患有高血压。 高血压可显著增加 PAD患者心血管事件和死亡的发  生风险[579] 。\n　　合理的降压治疗可降低 PAD患者心脑血管事件 的发生率和截肢率 ,收缩压每降低 10mmHg,PAD相 关的截肢或死亡率可降低 16%[580]  。对下肢动脉病有 血管重建指征的患者 ,及时合理地进行血管重建可以 显著提高行走能力和生活质量 ,有助于控制血压和降 低心血管风险。\n　8.5.2   降压目标    目前 ,该类患者是否需要严格控制 血压尚有争议 。在降压治疗过程中患肢血流可能下 降 ,但大多数患者仍可耐受 ,仅少数严重缺血患者可能 会出现血流进一步下降 ,导致症状加重 ,尤其要避免过\n\n\n度降压 。 国 际 缓 释 维 拉 帕 米-群 多 普 利 研 究 随 访  2.7年显示 ,PAD患者心血管事件发生率和血压控制  水平呈J形曲线 ,血压维持在 135~145/60~90mmHg 时 ,心血管风险最低 。对于存在下肢动脉疾病的高血  压患者 ,血压应控制在<140/90mmHg[581]  ,对于存在  糖尿病和 CKD 的患者 , 如能耐受 , 血压应控制\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>PAD<|>EVENT<|>Peripheral Artery Disease (PAD) is a condition affecting the peripheral arteries, with a prevalence of 3%-10% in the general population and 15%-20% in individuals over 70 years old. Hypertension is a significant risk factor for PAD, and proper blood pressure management can reduce cardiovascular events and amputation rates in PAD patients.\")\n##\n(\"entity\"<|>ACEI<|>ORGANIZATION<|>Angiotensin-Converting Enzyme Inhibitors (ACEI) are recommended as initial antihypertensive therapy for patients with PAD.\")\n##\n(\"entity\"<|>ARB<|>ORGANIZATION<|>Angiotensin Receptor Blockers (ARB) are recommended as initial antihypertensive therapy for patients with PAD.\")\n##\n(\"entity\"<|>CCB<|>ORGANIZATION<|>Calcium Channel Blockers (CCB) are recommended as part of the initial combined antihypertensive therapy for patients with PAD.\")\n##\n(\"entity\"<|>DIURETICS<|>ORGANIZATION<|>Diuretics are recommended as part of the initial combined antihypertensive therapy for patients with PAD.\")\n##\n(\"entity\"<|>BETA RECEPTOR BLOCKERS<|>ORGANIZATION<|>Beta receptor blockers are considered for use in antihypertensive therapy for patients with PAD.\")\n##\n(\"relationship\"<|>PAD<|>ACEI<|>ACEI is recommended as initial antihypertensive therapy for patients with PAD.<|>7)\n##\n(\"relationship\"<|>PAD<|>ARB<|>ARB is recommended as initial antihypertensive therapy for patients with PAD.<|>7)\n##\n(\"relationship\"<|>PAD<|>CCB<|>CCB is recommended as part of the initial combined antihypertensive therapy for patients with PAD.<|>6)\n##\n(\"relationship\"<|>PAD<|>DIURETICS<|>Diuretics are recommended as part of the initial combined antihypertensive therapy for patients with PAD.<|>6)\n##\n(\"relationship\"<|>PAD<|>BETA RECEPTOR BLOCKERS<|>Beta receptor blockers are considered for use in antihypertensive therapy for patients with PAD.<|>5)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_55e4577f2306d0aaad7d0993930abdcbf4dcbf893bd5d5b3ac7cb1b1263bd10a_v2"}